26 state attorneys general urge Medicare to cover Alzheimer’s treatments
(By Rylee Wilson for Becker’s Hospital Review) Twenty-six state attorneys general are asking Medicare to cover monoclonal antibody treatments for
Read More
Part D/Prescription Drugs
Half of All Eligible Medicare Beneficiaries Are Now Enrolled in Private Medicare Advantage Plans
(By Jeannie Fuglesten Biniek, Meredith Freed, Anthony Damico, and Tricia Neuman for Kaiser Family Foundation published May 01, 2023) According
Read MoreMore enrollees choosing higher-premium Medicare Advantage, Part D plans
(Rylee Wilson for Becker’s Hospital Review) The average premium cost for Medicare Advantage plans sold on eHealth increased from $6
Read MoreAHIP, AHA point fingers on cost of specialty drugs
(By Rylee Wilson for Becker’s Hospital Review) Insurer groups say hospitals are to blame for higher costs of specialty drugs,
Read MoreHospitals will spend up to 3% more on drugs in 2023, study finds
(By Paige Twenter for Becker’s Hospital Review) Nonfederal hospitals’ costs have hovered around $35 billion to $40 billion since 2018,
Read MoreMedicare to cover new Alzheimer’s drugs, Eli Lilly says
(By Jakob Emerson for Becker’s Hospital Review) Eli Lilly is expecting CMS to reverse course on its Medicare coverage policies
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for Kaiser Family Foundation Published: Apr 20, 2023) The Inflation Reduction Act of 2022 (the Act), signed
Read MoreMedicare drug pricing proposal not true negotiation, pharma group says
(By Rylee Wilson for Becker’s Hospital Review) Pharmaceutical Research and Manufacturers of America says CMS’ guidance for Medicare drug price
Read MoreKey senators make a big pivot on bipartisan insulin cost proposal
(By Rachel Cohrs for STAT) WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate,
Read MoreMost drugs likely to be selected for Medicare price negotiation have low therapeutic benefit, study finds
(By Rylee Wilson for Becker’s Hospital Review) Seven of the 10 drugs most likely to be selected for Medicare price negotiation
Read More